HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

CI 1044

inhibits PDE4; structure in first source
Also Known As:
CI-1044; N-(9-amino-4-oxo-1-phenyl-3,4,6,7-tetrahydro(1,4)diazepino(6,7,1-hi)indol-3-yl)nicotinamide
Networked: 9 relevant articles (0 outcomes, 4 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Chevalier, Stephan: 4 articles (01/2009 - 01/2007)
2. Sobry, Cécile: 4 articles (01/2009 - 01/2007)
3. Freslon, Jean-Louis: 3 articles (01/2009 - 01/2007)
4. Daguès, Nicolas: 3 articles (06/2008 - 01/2007)
5. Hanton, Gilles: 3 articles (06/2008 - 01/2007)
6. Lagente, Vincent: 2 articles (02/2010 - 03/2005)
7. Pawlowski, Valérie: 2 articles (11/2007 - 01/2007)
8. Sheth, Christopher M: 1 article (07/2011)
9. Lawton, Michael P: 1 article (07/2011)
10. Peters, David: 1 article (07/2011)

Related Diseases

1. Vascular System Injuries
2. Necrosis
3. Inflammation
4. Chronic Obstructive Pulmonary Disease (COPD)
5. Lung Injury

Related Drugs and Biologics

1. Phosphodiesterase 4 Inhibitors
2. Type 4 Cyclic Nucleotide Phosphodiesterases
3. Rolipram
4. Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
5. Cilomilast
6. Dexamethasone (Maxidex)
7. Phosphodiesterase 3 Inhibitors
8. Transforming Growth Factor beta1 (TGF beta 1)
9. Cytokines
10. Antigens

Related Therapies and Procedures

1. Aftercare (After-Treatment)